SCHEMBL8289676

SCHEMBL8289676

C=CCNC(=O)C(=O)[C@@H]1CCCCCCCCC[C@H](NC(=O)NC2(CS(=O)(=O)C(C)(C)C)CCCCC2)C(=O)N2C[C@@H]3C[C@@H]3[C@H]2C(=O)N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14597293 0.89 — —
SCHEMBL7857262 0.89 — —
SCHEMBL12608040 0.89 — —
SCHEMBL16297967 0.89 — —
SCHEMBL7860508 0.83 — —
SCHEMBL12606655 0.82 — —
SCHEMBL12607439 0.82 ADAM17 (0.31) —
SCHEMBL8291498 0.81 GAA (0.32) —
SCHEMBL8290411 0.81 GAA (0.32) —
SCHEMBL13685729 0.81 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005030796-A1 MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS NS3 SERINE PROTEASE SCHERING CORPORATION (US) 2005-04-07 — — WO disclosed
Send feedback